N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen

The preparation of a series of novel analogues of the selective antiestrogen tamoxifen is reported. 1 Z-alkoxyphenyl group in tamoxifen has been replaced by a N-alkoxypyrazole, while functionalised phenyl groups or heteroaromatics were introduced at the 2 Z-position using sequential Suzuki cross cou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2003-04, Vol.11 (8), p.1883-1899
Hauptverfasser: Wenckens, Martin, Jakobsen, Palle, Vedsø, Per, Huusfeldt, Per Olaf, Gissel, Birgitte, Barfoed, Marianne, Lundin Brockdorff, Bettina, Lykkesfeldt, Anne E, Begtrup, Mikael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1899
container_issue 8
container_start_page 1883
container_title Bioorganic & medicinal chemistry
container_volume 11
creator Wenckens, Martin
Jakobsen, Palle
Vedsø, Per
Huusfeldt, Per Olaf
Gissel, Birgitte
Barfoed, Marianne
Lundin Brockdorff, Bettina
Lykkesfeldt, Anne E
Begtrup, Mikael
description The preparation of a series of novel analogues of the selective antiestrogen tamoxifen is reported. 1 Z-alkoxyphenyl group in tamoxifen has been replaced by a N-alkoxypyrazole, while functionalised phenyl groups or heteroaromatics were introduced at the 2 Z-position using sequential Suzuki cross coupling of 1,2-(bis)borylpinacol 1-phenylbutene with 4- or 5-iodo-1- N, N-dimethylaminoethyl or propyl-pyrazoles. Approximately 50 tamoxifen analogues were obtained and tested in an estrogen receptor (ERα) affinity assay. Several compounds exhibited binding affinities 2–5-fold lower than tamoxifen. Dose–response experiments with six selected compounds were carried out using two different human breast cancer cell lines, MCF-7 and the tamoxifen resistant cell line MCF-/TAM R-1. Both cell lines exhibited growth inhibition upon treatment with the tamoxifen analogues. Co-treatment of the cells, with estradiol and the individual compounds, were also performed. The results indicated that the observed growth inhibitory effect was mediated by the ERα. Analogues of the potent antiestrogen 4-hydroxytamoxifen (4-OHT) were synthesised where the 1 E-4-hydroxyphenyl was replaced by a 1-hydroxypyrazol-4-yl group. However, modest growth inhibition of MCF-7 cells was observed upon treatment with these analogues. In contrast, 1 Z-, 2 Z-ringclosed tamoxifen analogue ( 59) was shown to possess antiproliferative effects on MCF-7 and MCF-/TAM R-1 cells in lower doses than tamoxifen. Graphic
doi_str_mv 10.1016/S0968-0896(02)00566-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73145163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089602005667</els_id><sourcerecordid>73145163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-8dbb6b3999502a2662d69dfb6fb7bd0d935db42955d3736a20a8644c8a9e616f3</originalsourceid><addsrcrecordid>eNqF0E1P3DAQgGELtYJl6U8A5dKKHtL6cxKfKoRoqYTaQ-nZ8scEDEm82FnE9tc3sKty7MmXZ2asl5BjRj8xyuDzL6qhrWmr4ZTyj5QqgLrZIwsmQdZCaPaGLP6RA3JYyh2llEvN9skB46B006gFufxRn_X36Wmz2mT7J_VYKlsqF9MQB5yiL1WXcjXdYmW37BbHTV_d5LReVXGsJjukp9jheETedrYv-G73LsnvrxfX55f11c9v38_PrmovGjnVbXAOnNBaK8otB-ABdOgcdK5xgQYtVHCSa6WCaARYTm0LUvrWagQGnViSD9u9q5we1lgmM8Tise_tiGldTCOYVAzEDNUW-pxKydiZVY6DzRvDqHlOaF4Smuc-hnLzknAeX5KT3YG1GzC8Tu2azeD9Dtjibd9lO_pYXp0EMa-Ss_uydTjneIyYTfERR48hZvSTCSn-5yt_ATMBjf0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73145163</pqid></control><display><type>article</type><title>N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wenckens, Martin ; Jakobsen, Palle ; Vedsø, Per ; Huusfeldt, Per Olaf ; Gissel, Birgitte ; Barfoed, Marianne ; Lundin Brockdorff, Bettina ; Lykkesfeldt, Anne E ; Begtrup, Mikael</creator><creatorcontrib>Wenckens, Martin ; Jakobsen, Palle ; Vedsø, Per ; Huusfeldt, Per Olaf ; Gissel, Birgitte ; Barfoed, Marianne ; Lundin Brockdorff, Bettina ; Lykkesfeldt, Anne E ; Begtrup, Mikael</creatorcontrib><description>The preparation of a series of novel analogues of the selective antiestrogen tamoxifen is reported. 1 Z-alkoxyphenyl group in tamoxifen has been replaced by a N-alkoxypyrazole, while functionalised phenyl groups or heteroaromatics were introduced at the 2 Z-position using sequential Suzuki cross coupling of 1,2-(bis)borylpinacol 1-phenylbutene with 4- or 5-iodo-1- N, N-dimethylaminoethyl or propyl-pyrazoles. Approximately 50 tamoxifen analogues were obtained and tested in an estrogen receptor (ERα) affinity assay. Several compounds exhibited binding affinities 2–5-fold lower than tamoxifen. Dose–response experiments with six selected compounds were carried out using two different human breast cancer cell lines, MCF-7 and the tamoxifen resistant cell line MCF-/TAM R-1. Both cell lines exhibited growth inhibition upon treatment with the tamoxifen analogues. Co-treatment of the cells, with estradiol and the individual compounds, were also performed. The results indicated that the observed growth inhibitory effect was mediated by the ERα. Analogues of the potent antiestrogen 4-hydroxytamoxifen (4-OHT) were synthesised where the 1 E-4-hydroxyphenyl was replaced by a 1-hydroxypyrazol-4-yl group. However, modest growth inhibition of MCF-7 cells was observed upon treatment with these analogues. In contrast, 1 Z-, 2 Z-ringclosed tamoxifen analogue ( 59) was shown to possess antiproliferative effects on MCF-7 and MCF-/TAM R-1 cells in lower doses than tamoxifen. Graphic</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/S0968-0896(02)00566-7</identifier><identifier>PMID: 12659775</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Antineoplastic agents ; Benzene Derivatives - chemistry ; Benzene Derivatives - pharmacology ; Biological and medical sciences ; Biomimetic Materials - chemistry ; Biomimetic Materials - pharmacology ; Breast Neoplasms - drug therapy ; Breast Neoplasms - metabolism ; Cell Division - drug effects ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm ; Estradiol - pharmacology ; Estrogen Receptor alpha ; Female ; General aspects ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Pyrazoles - chemistry ; Pyrazoles - pharmacology ; Receptors, Estrogen - drug effects ; Receptors, Estrogen - metabolism ; Tamoxifen - analogs &amp; derivatives ; Tamoxifen - pharmacology ; Tumor Cells, Cultured</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2003-04, Vol.11 (8), p.1883-1899</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-8dbb6b3999502a2662d69dfb6fb7bd0d935db42955d3736a20a8644c8a9e616f3</citedby><cites>FETCH-LOGICAL-c374t-8dbb6b3999502a2662d69dfb6fb7bd0d935db42955d3736a20a8644c8a9e616f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089602005667$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14630564$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12659775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wenckens, Martin</creatorcontrib><creatorcontrib>Jakobsen, Palle</creatorcontrib><creatorcontrib>Vedsø, Per</creatorcontrib><creatorcontrib>Huusfeldt, Per Olaf</creatorcontrib><creatorcontrib>Gissel, Birgitte</creatorcontrib><creatorcontrib>Barfoed, Marianne</creatorcontrib><creatorcontrib>Lundin Brockdorff, Bettina</creatorcontrib><creatorcontrib>Lykkesfeldt, Anne E</creatorcontrib><creatorcontrib>Begtrup, Mikael</creatorcontrib><title>N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>The preparation of a series of novel analogues of the selective antiestrogen tamoxifen is reported. 1 Z-alkoxyphenyl group in tamoxifen has been replaced by a N-alkoxypyrazole, while functionalised phenyl groups or heteroaromatics were introduced at the 2 Z-position using sequential Suzuki cross coupling of 1,2-(bis)borylpinacol 1-phenylbutene with 4- or 5-iodo-1- N, N-dimethylaminoethyl or propyl-pyrazoles. Approximately 50 tamoxifen analogues were obtained and tested in an estrogen receptor (ERα) affinity assay. Several compounds exhibited binding affinities 2–5-fold lower than tamoxifen. Dose–response experiments with six selected compounds were carried out using two different human breast cancer cell lines, MCF-7 and the tamoxifen resistant cell line MCF-/TAM R-1. Both cell lines exhibited growth inhibition upon treatment with the tamoxifen analogues. Co-treatment of the cells, with estradiol and the individual compounds, were also performed. The results indicated that the observed growth inhibitory effect was mediated by the ERα. Analogues of the potent antiestrogen 4-hydroxytamoxifen (4-OHT) were synthesised where the 1 E-4-hydroxyphenyl was replaced by a 1-hydroxypyrazol-4-yl group. However, modest growth inhibition of MCF-7 cells was observed upon treatment with these analogues. In contrast, 1 Z-, 2 Z-ringclosed tamoxifen analogue ( 59) was shown to possess antiproliferative effects on MCF-7 and MCF-/TAM R-1 cells in lower doses than tamoxifen. Graphic</description><subject>Antineoplastic agents</subject><subject>Benzene Derivatives - chemistry</subject><subject>Benzene Derivatives - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biomimetic Materials - chemistry</subject><subject>Biomimetic Materials - pharmacology</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - metabolism</subject><subject>Cell Division - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Neoplasm</subject><subject>Estradiol - pharmacology</subject><subject>Estrogen Receptor alpha</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrazoles - pharmacology</subject><subject>Receptors, Estrogen - drug effects</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Tamoxifen - analogs &amp; derivatives</subject><subject>Tamoxifen - pharmacology</subject><subject>Tumor Cells, Cultured</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1P3DAQgGELtYJl6U8A5dKKHtL6cxKfKoRoqYTaQ-nZ8scEDEm82FnE9tc3sKty7MmXZ2asl5BjRj8xyuDzL6qhrWmr4ZTyj5QqgLrZIwsmQdZCaPaGLP6RA3JYyh2llEvN9skB46B006gFufxRn_X36Wmz2mT7J_VYKlsqF9MQB5yiL1WXcjXdYmW37BbHTV_d5LReVXGsJjukp9jheETedrYv-G73LsnvrxfX55f11c9v38_PrmovGjnVbXAOnNBaK8otB-ABdOgcdK5xgQYtVHCSa6WCaARYTm0LUvrWagQGnViSD9u9q5we1lgmM8Tise_tiGldTCOYVAzEDNUW-pxKydiZVY6DzRvDqHlOaF4Smuc-hnLzknAeX5KT3YG1GzC8Tu2azeD9Dtjibd9lO_pYXp0EMa-Ss_uydTjneIyYTfERR48hZvSTCSn-5yt_ATMBjf0</recordid><startdate>20030417</startdate><enddate>20030417</enddate><creator>Wenckens, Martin</creator><creator>Jakobsen, Palle</creator><creator>Vedsø, Per</creator><creator>Huusfeldt, Per Olaf</creator><creator>Gissel, Birgitte</creator><creator>Barfoed, Marianne</creator><creator>Lundin Brockdorff, Bettina</creator><creator>Lykkesfeldt, Anne E</creator><creator>Begtrup, Mikael</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030417</creationdate><title>N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen</title><author>Wenckens, Martin ; Jakobsen, Palle ; Vedsø, Per ; Huusfeldt, Per Olaf ; Gissel, Birgitte ; Barfoed, Marianne ; Lundin Brockdorff, Bettina ; Lykkesfeldt, Anne E ; Begtrup, Mikael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-8dbb6b3999502a2662d69dfb6fb7bd0d935db42955d3736a20a8644c8a9e616f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antineoplastic agents</topic><topic>Benzene Derivatives - chemistry</topic><topic>Benzene Derivatives - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biomimetic Materials - chemistry</topic><topic>Biomimetic Materials - pharmacology</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - metabolism</topic><topic>Cell Division - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Neoplasm</topic><topic>Estradiol - pharmacology</topic><topic>Estrogen Receptor alpha</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrazoles - pharmacology</topic><topic>Receptors, Estrogen - drug effects</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Tamoxifen - analogs &amp; derivatives</topic><topic>Tamoxifen - pharmacology</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wenckens, Martin</creatorcontrib><creatorcontrib>Jakobsen, Palle</creatorcontrib><creatorcontrib>Vedsø, Per</creatorcontrib><creatorcontrib>Huusfeldt, Per Olaf</creatorcontrib><creatorcontrib>Gissel, Birgitte</creatorcontrib><creatorcontrib>Barfoed, Marianne</creatorcontrib><creatorcontrib>Lundin Brockdorff, Bettina</creatorcontrib><creatorcontrib>Lykkesfeldt, Anne E</creatorcontrib><creatorcontrib>Begtrup, Mikael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wenckens, Martin</au><au>Jakobsen, Palle</au><au>Vedsø, Per</au><au>Huusfeldt, Per Olaf</au><au>Gissel, Birgitte</au><au>Barfoed, Marianne</au><au>Lundin Brockdorff, Bettina</au><au>Lykkesfeldt, Anne E</au><au>Begtrup, Mikael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2003-04-17</date><risdate>2003</risdate><volume>11</volume><issue>8</issue><spage>1883</spage><epage>1899</epage><pages>1883-1899</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>The preparation of a series of novel analogues of the selective antiestrogen tamoxifen is reported. 1 Z-alkoxyphenyl group in tamoxifen has been replaced by a N-alkoxypyrazole, while functionalised phenyl groups or heteroaromatics were introduced at the 2 Z-position using sequential Suzuki cross coupling of 1,2-(bis)borylpinacol 1-phenylbutene with 4- or 5-iodo-1- N, N-dimethylaminoethyl or propyl-pyrazoles. Approximately 50 tamoxifen analogues were obtained and tested in an estrogen receptor (ERα) affinity assay. Several compounds exhibited binding affinities 2–5-fold lower than tamoxifen. Dose–response experiments with six selected compounds were carried out using two different human breast cancer cell lines, MCF-7 and the tamoxifen resistant cell line MCF-/TAM R-1. Both cell lines exhibited growth inhibition upon treatment with the tamoxifen analogues. Co-treatment of the cells, with estradiol and the individual compounds, were also performed. The results indicated that the observed growth inhibitory effect was mediated by the ERα. Analogues of the potent antiestrogen 4-hydroxytamoxifen (4-OHT) were synthesised where the 1 E-4-hydroxyphenyl was replaced by a 1-hydroxypyrazol-4-yl group. However, modest growth inhibition of MCF-7 cells was observed upon treatment with these analogues. In contrast, 1 Z-, 2 Z-ringclosed tamoxifen analogue ( 59) was shown to possess antiproliferative effects on MCF-7 and MCF-/TAM R-1 cells in lower doses than tamoxifen. Graphic</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12659775</pmid><doi>10.1016/S0968-0896(02)00566-7</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2003-04, Vol.11 (8), p.1883-1899
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_73145163
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antineoplastic agents
Benzene Derivatives - chemistry
Benzene Derivatives - pharmacology
Biological and medical sciences
Biomimetic Materials - chemistry
Biomimetic Materials - pharmacology
Breast Neoplasms - drug therapy
Breast Neoplasms - metabolism
Cell Division - drug effects
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Estradiol - pharmacology
Estrogen Receptor alpha
Female
General aspects
Humans
Medical sciences
Pharmacology. Drug treatments
Pyrazoles - chemistry
Pyrazoles - pharmacology
Receptors, Estrogen - drug effects
Receptors, Estrogen - metabolism
Tamoxifen - analogs & derivatives
Tamoxifen - pharmacology
Tumor Cells, Cultured
title N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T06%3A12%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-Alkoxypyrazoles%20as%20biomimetics%20for%20the%20alkoxyphenyl%20group%20in%20tamoxifen&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Wenckens,%20Martin&rft.date=2003-04-17&rft.volume=11&rft.issue=8&rft.spage=1883&rft.epage=1899&rft.pages=1883-1899&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/S0968-0896(02)00566-7&rft_dat=%3Cproquest_cross%3E73145163%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73145163&rft_id=info:pmid/12659775&rft_els_id=S0968089602005667&rfr_iscdi=true